U.S. in touch with Indian vaccine makers: Envoy
The Hindu
We’re trying to determine raw materials we could provide to address shortfall, he says
The United States has been in contact with the Serum Institute of India and other vaccine manufacturers to boost production of vaccines against COVID-19, said the U.S. envoy to India on Tuesday. Addressing a virtual press meet, Charge d’Affaires Ambassador Daniel B Smith described the second wave in India as a development that has “global implications” and expressed continued support from the Biden administration which has committed $100 million in assistance. “We are watching carefully the production levels at the SII and elsewhere. We have been in close touch with the SII to try to determine what raw materials we could provide, and assistance that we can provide to help boost production,” said Mr. Smith. “The U.S. has also diverted enough of Oxford AstraZeneca manufacturing supplies from its own pre-existing orders to produce over 20 million vaccine doses in India.”More Related News